{
    "clinical_study": {
        "@rank": "75386", 
        "arm_group": {
            "arm_group_label": "Pacemaker", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "An evaluation of a safety and performance of a new cardiac pacemaker"
        }, 
        "brief_title": "Evaluation of a New Cardiac Pacemaker", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Atrial Fibrillation With 2 or 3\u00b0 AV or Bifascicular Bundle Branch (BBB) Block", 
            "Normal Sinus Rhythm With 2 or 3\u00b0 AV or BBB Block", 
            "Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Syncope", 
                "Sick Sinus Syndrome", 
                "Bradycardia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must have one of the following clinical indications:\n\n               1. Chronic atrial fibrillation  with 2 or 3\u00b0 AV or bifascicular bundle branch block\n                  (BBB block) ; or\n\n               2. Normal sinus rhythm with 2 or 3\u00b0 AV or BBB block  and a low level of physical\n                  activity or short expected lifespan (but at least one year); or\n\n               3. Sinus bradycardia with infrequent pauses or unexplained syncope with EP\n                  findings; and\n\n          -  Subject \u226518 years of age;\n\n          -  Subject has life expectancy of at least one year;\n\n          -  Subject is not enrolled in another clinical investigation;\n\n          -  Subject is willing to comply with clinical investigation procedures and agrees to\n             return for all required follow-up visits, tests, and exams;\n\n          -  Subject has been informed of the nature of the study, agrees to its provisions and\n             has provided written informed consent, approved by the EC;\n\n          -  If female, for 3 months post-operative, subject will actively practice a\n             contraception method, or will practice abstinence, or is surgically sterilized, or is\n             postmenopausal.\n\n        Exclusion Criteria:\n\n          -  Pacemaker dependent;\n\n          -  Known pacemaker syndrome, have retrograde VA conduction or suffer a drop in arterial\n             blood pressure with the onset of ventricular pacing;\n\n          -  Hypersensitivity to < 1 mg of dexamethasone sodium phosphate;\n\n          -  Mechanical tricuspid valve prosthesis;\n\n          -  Pre-existing pulmonary arterial (PA) hypertension  or significant\n             physiologically-impairing lung disease;\n\n          -  Pre-existing  pacing or defibrillation leads;\n\n          -  Current implantation of an implantable cardioverter defibrillator (ICD) or cardiac\n             resynchronization therapy (CRT);\n\n          -  Presence of implanted vena cava filter;\n\n          -  Presence of implanted leadless cardiac pacemaker;\n\n          -  Pregnant or breastfeeding."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01700244", 
            "org_study_id": "LCP004"
        }, 
        "intervention": {
            "arm_group_label": "Pacemaker", 
            "intervention_name": "Pacemaker implant", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 25, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Prague 5", 
                        "country": "Czech Republic", 
                        "state": "Prague", 
                        "zip": "15000"
                    }, 
                    "name": "Na Homolce Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Prague 4", 
                        "country": "Czech Republic", 
                        "zip": "140 21"
                    }, 
                    "name": "IKEM"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Nauheim", 
                        "country": "Germany", 
                        "zip": "61231"
                    }, 
                    "name": "Kerckhoff Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "zip": "04103"
                    }, 
                    "name": "University Hospital Leipzig"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80636"
                    }, 
                    "name": "Heart Hospital Munich"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105"
                    }, 
                    "name": "Academic Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nieuwegein", 
                        "country": "Netherlands", 
                        "zip": "3430"
                    }, 
                    "name": "St. Antonius Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584"
                    }, 
                    "name": "UMC Utrecht"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "Germany", 
                "Netherlands"
            ]
        }, 
        "number_of_arms": "1", 
        "overall_official": {
            "affiliation": "Kerckhoff Clinic", 
            "last_name": "Johannes Sperzel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Czech Republic: SUKL - State Institute for Drug Control", 
                "Germany: BfArM - Federal Institute for Drugs and Medical Devices", 
                "Netherlands: METC - Medical Ethics Review Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Complication rate, where a complication is defined as a serious adverse device effect (SADE)", 
            "safety_issue": "Yes", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01700244"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Nanostim, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nanostim, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}